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Abstract 
Studies of the real-time dynamics of embryonic development require a gentle embryo handling 
method, the possibility of long-term live imaging during the complete embryogenesis, as well as 
of parallelization providing a population’s statistics, while keeping single embryo resolution. We 
describe an automated approach that fully accomplishes these requirements for embryos of 
Caenorhabditis elegans, one of the most employed model organisms in biomedical research. We 
developed a microfluidic platform which makes use of pure passive hydrodynamics to run on-chip 
worm cultures, from which we obtain synchronized embryo populations, and to immobilize these 
embryos in incubator microarrays for long-term high-resolution optical imaging. We successfully 
employ our platform to investigate morphogenesis and mitochondrial biogenesis during the full 
embryonic development and elucidate the role of the mitochondrial unfolded protein response 
(UPRmt) within C.elegans embryogenesis. Our method can be generally used for protein 
expression and developmental studies at the embryonic level, but can also provide clues to 
understand the aging process and age-related diseases in particular. 
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Introduction 
Exposure to particular environmental conditions during early life is often decisive for later 
successful development of a living organism. In C. elegans, events occurring during larval stages 
are known to have a strong impact on the animal’s lifespan1. Whether conditions in the embryonic 
phase of life have an influence on the later development is a much more challenging question to 
answer, mainly because systematic C. elegans embryonic morphogenesis studies are still difficult 
from a technical point of view. In fact, C. elegans worm culture is performed on the surface of 
nematode growth medium agar plates covered with Escherichia coli bacteria for feeding. This 
technique proves especially tedious if large numbers of animals are to be analyzed. Moreover, 
for embryonic studies, currently available protocols are based on animal dissection and embryo 
mounting on agar pads2, which typically require specialized and advanced skills and lacks 
reproducibility and high-throughput potential. Recently, it has been shown that various aspects of 
functional exploration of C. elegans can be significantly improved using microfluidics3-8. “Worm-
chips” have successfully demonstrated their high potential at enhancing worms’ handling and 
accurate imaging, for applications in lifespan studies9, phenotyping and screening10,11, nerve 
regeneration analyses12, as well as for the investigation of worms’ behavioral dynamics13. So far, 
however, such robust methods to study C. elegans embryos do not exist yet, whereas a 
microfluidic solution has been only proposed to study early embryo development for larger size 
model organisms, like Drosophila melanogaster and Danio rerio14, 15. C. elegans embryos are 10-
100 times smaller than those of the other small model organisms and almost impossible to handle 
manually.  
To enable systematic analysis of C.elegans embryonic morphogenesis, we developed a 
microfluidic platform for automated on-chip worm culture, creation of synchronized embryo arrays, 
and for long-term parallel live imaging at the single embryo level. We successfully employed our 
platform to investigate mitochondrial biogenesis during the embryonic development. Using our 
 4
method to study a large number of embryos of different wild-type and mutant worm strains, we 
elucidated an outstanding issue regarding the role of UPRmt during early worm embryogenesis. 
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Results 
Platform design and automated operation 
The robustness and automation of our system completely relies on passive hydrodynamics, with 
no need of any active component on-chip, such as integrated valves. This approach allows 
simplifying fluidic protocols and significantly minimizing fabrication constrains of the device, which 
simply consists of a monolithic polydimethylsiloxane (PDMS) microfluidic chip, sealed to a ~150 
μm-thick glass coverslip. Our microfluidic chip features two main components: a “worm culture 
chamber” and an “embryo-incubator array" (Fig.1a,bi). External flow control through four 
independent inlets is achieved via computer-controlled syringe pumps, while two external valves 
are used to open and close two separate outlets. The worm culture chamber is delimited by 
specific microfluidic channel arrangements for generating uniform flow distributions in the 
chamber and for filtering entities of different size (Fig.1bii and Fig.SI1): a “worm injection filter”, 
for gentle insertion of mixed worm suspensions into the chamber; a “worm synchronization filter”, 
to select the age of the worm population to be tested, by only retaining either adult worms or L4 
larvae inside the chamber; an “E.coli/drug delivery filter”, to homogeneously introduce feeding 
and treatment solutions inside the chamber; an “embryo transfer filter”, to reliably displace 
embryos from the chamber to the embryo-incubator array upon egg laying. The embryo-incubator 
array consists of a serpentine channel in which each pair of branches is connected by isolated 
micro-compartments, specifically tailored for the trapping of C. elegans embryos and their high-
resolution imaging through the glass coverslip (Fig.1biii). Embryos that are transferred to the 
embryo-incubator array are automatically positioned in the micro-incubators by passive 
hydrodynamic trapping (Fig.1c). The design of this section of the chip is optimized according to 
both general microfluidic rules and specific needs related to the characteristics of C.elegans 
embryos (Supplementary Note 2). Overall, our fluidic design results in enhanced efficiency of 
capture and stable positioning of single embryos, with unprecedented performance in terms of 
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control and reliability of the trapping mechanism for non-spherical objects (Supplementary Video 
1). The flow rate distribution inside the array has to ensure the capture of a single embryo for 
each micro-incubator. Since the number of available embryos is being limited by the egg 
production inside the chamber, a perfect efficiency of the hydrodynamic trapping method has to 
be established in order to recover all eggs. At the same time, however, high trapping efficiency is 
typically associated to higher fluidic pressures through the micro-incubators. Therefore, forces 
exerted on the incubated eggs have to be considered as well, to prevent the flow from introducing 
undesired mechanical stresses on the captured embryos.  A crucial role for the system 
performance is clearly played by the geometry of the micro-incubators, hence different types of 
micro-incubators have been fabricated and tested (Supplementary Note 3). For high-resolution 
parallel time-lapse imaging of the whole embryo population and automated image processing, all 
the embryos have to be perfectly arrayed in stable positions and kept correctly aligned and well-
oriented for several hours. We optimized the incubator size and shape mainly according to these 
needs, with our final design featuring elongated semicircular incubators, which are 35 μm wide, 
38 μm long and 35 μm high (Fig.1d). Using these dimensions, single embryos can be reliably 
positioned and aligned inside the incubator array (Fig.1e). Only slight variations in their angular 
positions are observed, given the natural size variability of the embryos (Supplementary Note 4). 
The whole incubator array features 20 micro-incubators, which are progressively filled by embryos 
as soon as they are naturally laid. This number is chosen to provide a significant data statistics 
for each experiment, while still maintaining a good level of age-synchronization among all the 
embryos in the array. For a worm culture, which is at the peak of its egg production, complete 
filling of the incubator array typically takes around 1 hour. The whole embryo population is studied 
using fully automated multi-dimensional imaging, covering six independent dimensions: the 3 
spatial coordinates, the development time, the exposure (brightfield, fluorescent) duration, and 
the embryo number in the array (Fig.1f).     
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In each experiment, worms and embryos are manipulated via sequences of fully automated 
operations (Fig. 2). The geometry of the chip is optimized for retaining inside the worm culture 
chamber only adult worms by washing out all the larvae present in a mixed worm suspension 
(zoom of Fig. 2a and Supplementary Video 2).  Alternatively, a L1-L4 larvae suspension can be 
injected at a lower flow rate to retain just L4 larvae inside the chamber. Eventually, the number of 
captured worms can be adapted by running an optional “washing step” (Supplementary Video 3). 
Upon isolation of a defined worm population inside the chamber, worms are cultured and can be 
eventually treated on-chip with specific drugs or chemicals (Fig. 2b). An appropriate flow of M9 
buffer allows recovering all the eggs present in the chamber and isolating each of them in a single 
micro-incubator via passive hydrodynamic trapping up to complete array filling (Fig. 2c and 
Supplementary Video 4). Parallel time-lapse imaging is then started, either for the full array or by 
scanning each individual embryo at high resolution, at desired frame rate, magnification and light 
wavelengths, depending on the analysis of interest (Fig. 2d).  
Automated analysis of embryonic morphogenesis  
A microscopy environmental control system maintains a constant temperature on the chip 
(typically 25°C) over the whole duration of each experiment. An automated xy-positioning stage 
is used to scan sequentially all positions of interest on the embryo incubator array. Embryos can 
be monitored at cellular resolution through a 63x, NA 1.4 oil immersion objective, thus allowing 
accurate observation and analysis of C. elegans embryonic morphogenesis stages (Fig. 3a) over 
the whole time-span, from egg capture to hatching (Fig. 3b and Supplementary Video 5). Two key 
events with clearly different morphological changes in the embryo shape can be distinguished: (i) 
the onset of the so-called “bean stage”, beginning of morphogenesis (Fig. 3c, top), and (ii) the 
onset of the “1.5-fold stage”, followed by the twitching inception (Fig. 3c, middle). Together with 
egg hatching (Fig. 3c, bottom), these morphological changes could be detected by software-
controlled pattern recognition codes, for the full automation of the image processing. 
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We recorded the duration of the two last development phases of Fig. 3c for full arrays of embryos 
(n=20) belonging to different strains (Supplementary Video 6). Our platform allowed accurate 
measurement of the duration of these phases for individual N2 wild-type embryos at 25°C (Fig. 
3di). The apparent variability is an indication of variations in the exact moment of egg laying (and 
subsequent trapping) of each embryo, which represents another interesting phenotype to be 
studied with our method as well. The average duration of the development phases could be 
monitored with good accuracy, even from this single array experiment (Fig. 3dii). Moreover, as 
worms could be cultured and maintained on the same chip for several days, we demonstrated the 
capability of our device to be employed for studying age-related changes in worm reproduction 
and progeny development (Supplementary Note 5).  
We systematically studied the duration of the different development phases for several transgenic 
strains and mutants (Fig. 3e and Supplementary Note 6). As for the wild-type, we could reliably 
determine the average duration of the bean to 1.5-fold stage phase (phase 2) (~90 min) and the 
average duration of the 1.5-fold stage to hatching phase (phase 3) (~280 min) in the eat-2(ad465), 
Pges-1::mito::gfp, hsp-6::gfp and Prab-3::cco-1HP;hsp-6::gfp strains. A weak increase of the 
phase 3 was measured with the Pmyo-3::mito::gfp transgenic strain, which is in accordance with 
the slight developmental delay observed during the larval stage (data not shown). A more 
significant 1.3-fold increase of phase 3 is instead observed in the mev-1 mutants, while for the 
isp-1(qm150) mutants, both phases 2 and 3 were more than two times longer compared to the 
control worms. These results already highlight the importance of the mitochondrial electron 
transport chain function during embryogenesis (Supplementary Note 6).  
Eventually, the possibility of automated on-chip chemical or drug treatment was validated by 
exposing the worms to the anticancer drug, 5-fluorouracil (5-FU). This compound induces cell-
cycle arrest and apoptosis of germ-line cells in C.elegans16. In our experiment, wild-type worms 
were isolated in the culture chamber at the L4 larval stage and treated on-chip with 5-FU at a 
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concentration of 2 mM, while being cultured at 25°C towards the adult stage. After washing the 
chamber with clean M9 buffer, successively laid embryos were transferred to the incubator array 
and monitored for 12 h. All embryos prematurely died, proving the efficiency of the drug exposure 
of the worms in the culture chamber of the chip (Fig. 3f). 
Study of mitochondrial biogenesis during embryonic development  
Knowing that the knockdown of many mitochondrial genes can induce embryonic lethality or result 
in an infertile phenotype, we investigated mitochondrial function and biogenesis during 
embryogenesis, focusing on the molecular pathway known as mitochondrial unfolded protein 
response (UPRmt). The latter is an adaptive response that monitors and subsequently repairs 
abnormal proteostasis within the mitochondria and, as such, ensures the proper function and 
integrity of the mitochondria17, 18. In C.elegans, it has been shown that UPRmt is most effective 
when triggered during larval development, resulting in a permanent adaptive protection of the 
mitochondria throughout life and, as such, increasing the animal’s survival rate (Fig. 4a). This 
careful control of mitochondrial activity early in life seems to setup a proper rate of aging, which 
persists throughout life, probably through the establishment of epigenetic imprints19. However, it 
is still unknown whether the UPRmt is operational during the earliest phases of the life, i.e. 
embryonic development. As tackling this problem requires the careful analysis of multiple 
parameters in a spatio-temporal controlled fashion in a living embryo, we used our platform to 
address this challenging question. 
Before measuring the UPRmt activity, we first investigated whether mitochondrial biogenesis could 
be detected and monitored in two different tissues in embryos, i.e. the muscle and the intestine. 
Indeed, a proper mitochondrial proliferation and activity is a prerequisite for the induction of a 
mitochondrial stress. Two transgenic strains of worms were used, expressing Green Fluorescent 
Protein (GFP) either in the mitochondria of the body wall muscle cells, i.e. the Pmyo-3::mito::gfp 
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worm strain SJ4103, or in the intestinal cells, i.e. the Pges-1::mito::gfp worm strain SJ414320. 
Larvae or adult worms of these strains are commonly used to monitor the mitochondrial activity, 
proliferation and morphology21, 22. Brightfield and fluorescent pictures of the same embryo were 
quasi-simultaneously recorded and superimposed, permitting accurate localization of the 
fluorescent signal. Interestingly, our analysis revealed that mitochondrial proliferation takes place 
in both muscle and intestinal cells (Fig. 4b-g and Supplementary Video 7, Fig. 4h-m and 
Supplementary Video 8). The mitochondrial biogenesis looks different in terms of intensity 
between muscle and intestinal cells, probably due to the different number and role of 
mitochondria, as it is clear when comparing Fig. 4b-d with Fig. 4h-j. Indeed, after the 1.5-fold 
stage of embryogenesis, most cellular proliferation and migration of the body wall muscles are 
completed and the worm starts twitching in the eggshell, requiring a sustained energy supply 
provided by the mitochondrial activity23. Beside the intensity of mitochondrial biogenesis during 
embryogenesis, our study revealed that mitochondrial proliferation behaves independently of 
tissue morphogenesis. While genetic markers of the body wall muscle and the intestinal cells 
significantly appear before the bean stage24, we observed a rather large delay regarding the onset 
of mitochondrial proliferation, highlighting a specific increase of the energy supply during the late 
phase of the embryo development (Fig. 4e-g and Fig. 4k-m). Furthermore, as already observed 
in mouse embryos, this late proliferation of mitochondria could coincide with the pronounced 
structural and functional differentiation of the mitochondria within the different tissues25. 
Interestingly, a previous study showed that the mitochondrial DNA copy number –which is 
indicative of the relative number of mitochondria in the organism – remains unchanged from the 
late embryo stage up to the L3 larval stage, whereas a five-fold increase occurs with the transition 
from L3 to L426. Our experimental observations suggest that a first increase in mitochondrial 
biogenesis actually takes place earlier, during the embryogenesis (Fig. 4g and Fig. 4m). Although 
embryonic mitochondrial biogenesis is less pronounced compared to that occurring during the L3 
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to L4 transition, it is significant and we speculate that it provides the necessary amount of 
mitochondria and energy, required for the first steps of the larval development.  
Study of mitochondrial unfolded protein response during embryogenesis 
We then investigated whether the UPRmt can also be detected during embryogenesis. To monitor 
the mitochondrial stress response in living embryos, we used a transgenic strain of worms that 
reports on the activity of the UPRmt with integrated GFP genes driven by the regulatory DNA 
region of the mitochondrial chaperone hsp-627. In these transgenic worms, an increase of hsp-
6::gfp expression is indicative of the presence of a mitochondrial stress and the subsequent 
induction of the UPRmt 28, 29. We first examined the UPRmt induction in unstressed embryos. 
Despite a pronounced mitochondrial proliferation occurring during the late phase of the 
embryogenesis, we did not observe a matching increase of hsp-6::gfp expression (Fig. 5a,d). This 
result is in agreement with previous reports showing an activation of the UPRmt during the L3 to 
L4 transition period, where a similar burst of mitochondrial biogenesis occurs only if a 
mitochondrial stress is experimentally induced 26, 28. Nevertheless, a careful monitoring and 
surveillance of mitochondrial stress is fundamental for the embryogenesis, as the loss of function 
of some UPRmt mediators, such as hsp-6 and dve-1, has been reported to lead to an early death 
of the worm embryos30, 31. To trigger a potential constitutive UPRmt in embryos, we first used the 
mutant strain MQ887 carrying a mutation in the isp-1 gene, which we crossed with the hsp-6::gfp 
worms. The resulting isp-1(qm150);hsp-6::gfp strain showed a constitutive activation of hsp-6::gfp 
in larvae and adult worms, revealing a strong and continuous mitochondrial stress28 
(Supplementary Note 7). By monitoring the hsp-6::gfp expression during the embryo 
development, we observed a 4- to 5-fold induction of the UPRmt, which matches the onset of 
mitochondrial biogenesis (Fig. 5b,e,g and Supplementary Video 9). Interestingly, this 
mitochondrial stress response seems to be more pronounced in the intestinal cells, which is in 
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accordance with previous observations in larvae and adults and confirms that this tissue is one of 
the prime sites for the activation of the UPRmt (Fig. 5i)28. 
While UPRmt can be activated in a cell-autonomous manner, as here illustrated in the intestine, 
this stress response can also be triggered in a cell-non-autonomous manner28. To explore this 
hypothesis, we used the hsp-6::gfp strain of worms carrying an additional transgene, which drives 
the knockdown of the mitochondrial gene cco-1 only in neurons, i.e. the Prab-3::cco-1HP;hsp-
6::gfp worm strain AGD1073 (Supplementary Note 8). In the post-embryonic phase of worm 
development, the silencing of cco-1 exclusively in neurons is sufficient to promote a mitochondrial 
stress that is propagated in distal tissues28. We observed a robust 2-fold induction of UPRmt when 
cco-1 is silenced in neuronal cells during the embryogenesis (Fig. 5c,f,h and Supplementary 
Video 10). Interestingly, the activation of the mitochondrial stress response seems independent 
of the rab-3 promoter activity –rab-3 starts being expressed in the early cell division stages24 – 
but rather a consequence of the concomitant mitochondrial proliferation and cco-1 knockdown. 
Furthermore, while the UPRmt induction takes place in the intestinal cells of the isp-1(qm150) 
embryos (Fig. 5i), neurons seem to be the primary cells for the mitochondrial stress response in 
the case of cco-1 silencing in the neuronal system (Fig. 5j). This difference between embryos and 
larvae concerning the lack of cell-non-autonomous activation of UPRmt could be explained by the 
fact that the neuronal and hormonal signalling pathways required for signal transmission are not 
yet fully developed at the embryonic stage. 
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Discussion 
In our platform, a well-defined and synchronized C. elegans embryo population can be isolated 
from an on-chip worm culture and studied in a fully automated way at extremely high spatial and 
temporal resolution. The device allows operation and analysis at the single-organism level, thus 
preserving the identity of each individual embryo, while at the same time providing statistics of 
the complete population. We demonstrated the capability of our platform to accurately analyze 
the real-time dynamics of different phases of the embryonic development, to monitor live protein 
expression in developing embryos during the complete embryogenesis, and to perform systematic 
studies that address outstanding issues in developmental biology.  
Our approach allows suppressing the bleaching step in the classical method, which is used for 
embryo harvesting and could affect the embryo integrity. Furthermore, our on-chip embryo 
synchronization allows using a minimal amount of gravid worms to obtain an accurate number of 
laid eggs. Finally, the limitation of the manual handling and the full automation of our protocol 
provide great advantages compared to the actual standard procedure, requiring several manual 
preparation steps (maintenance of a large worm population on solid agar plate, recovery of this 
worm population with the bleaching solution, washing of the egg preparation, egg transfer, etc.). 
In particular, we validated our platform by characterizing development, mitochondrial biogenesis 
and UPRmt in worm embryos at a precision that would have been very difficult or impossible to 
achieve with classical worm techniques. The imaging and monitoring of the embryogenesis 
require specific techniques, which imply single embryo isolation and its mounting2. Our 
microfluidic device is specifically designed to simplify and automate embryo handling, and only 
requires loading of a few adult worms into the chip. Furthermore, classical protocols for embryo 
analysis do not allow the concomitant monitoring of multiple replicates in identical biological 
conditions. The incubator array format of this platform provides a unique opportunity to study the 
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intra-embryo variability in terms of viability, development or gene expression. This platform allows 
the identification in a reproducible and accurate manner of the different phases of the C.elegans 
embryogenesis that occur after the egg laying, from the early cell division stages to hatching. We 
were able to discriminate variations in terms of embryonic development and describe how 
perturbations of the mitochondrial functions can profoundly impact on the embryogenesis.  
In C.elegans, the mitochondrial biogenesis mainly occurs during the late larval phase, i.e. during 
the L3 to L4 larval transition26. Here we described that another burst of mitochondrial biogenesis 
takes place during the last phase of the embryo development. This late embryonic proliferation of 
mitochondria seems to overlap with the differentiation of the mitochondria within the tissues, as 
revealed by the different profiles in term of biogenesis intensity and timing observed in muscle 
and intestinal tissues. Furthermore, while the mitochondrial biogenesis that occurs during the 
embryogenesis is less intense compared to the L3 to L4 transition, it is tempting to speculate that 
this late event in the embryo could be a prerequisite for the first steps of the larval development, 
by providing the required amount of mitochondria and energy. The crucial importance of the late 
phase of embryonic mitochondrial biogenesis is corroborated by the observation that several 
disturbances of the mitochondrial function during this specific period can impact later in the worm 
life32. 
In addition, we demonstrated that such perturbations of the mitochondrial function can trigger the 
UPRmt pathway in embryos. The activation of this specific mitochondrial stress response matches 
the onset of mitochondrial biogenesis, which is in accordance with what is observed in larvae. 
Furthermore, the UPRmt seems to work mainly in a cell autonomous manner in embryos, probably 
because the signalling pathways required for the signal transmission between neurons and the 
distal tissues are not yet fully developed at this stage of life. These observations are the first proof 
for the existence that UPRmt is functional during the embryogenesis. One could hypothesize that 
a mitochondrial stress restricted to the late phase of the embryo development could trigger a 
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beneficial effect during the rest of the life, opening the concept of a potential “mitochondrial 
imprinting” during the first step of the organism’s life. 
In the future, due to the versatility of our platform design, its live imaging capability can be readily 
extended to include other types of microscopies, like differential interference contrast microscopy, 
for high-contrast brightfield live imaging, and confocal microscopy to achieve extreme spatial 
resolution. Computer-enhanced image processing can be used to further extend the analytical 
possibilities of our platform for real-time embryonic screening and phenotyping, or even 
automated cell lineage and expression profiling in the developing embryos. In our device embryos 
are isolated immediately after they are naturally laid, thus their monitoring typically starts at the 
26 to 44-cell stage. However, with our system, earlier cell division events may be optionally 
observed by directly injecting embryo suspensions prepared via standard manual bleaching 
protocols into the device. As in our platform worms are directly cultured on-chip and embryos 
analyzed upon spontaneous egg-laying, the whole information related to the natural reproduction 
process is preserved, maintaining the link between parents and progeny. Therefore, the platform 
is directly suitable for investigating trans-generational properties on the embryos and, with some 
adaptation of the microfluidic design, even studying the progeny and epigenetic imprints in 
successive worm generations. Devices for related parasitic nematodes can be readily designed 
by re-adapting the incubator size, for example to study the effects of anti-parasitic drugs. Finally, 
we expect that similar microfluidic designs will be used to perform live imaging of a multitude of 
development events, like gastrulation and tissue morphogenesis during embryogenesis in other 
species of nematodes or other model organisms.  
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Methods 
 
Chemicals and Materials  
4-inch 550 µm thick Si and float glass wafers, de-ionized water (DIW) were obtained from the 
Center of Micro- and Nanotechnology of EPFL. GM 1070 SU-8 negative photoresist was 
purchased from Gersteltec (Pully, Switzerland). PDMS Sylgard 184 was acquired from Dow 
Corning (Wiesbaden, Germany). 1 mL borosilicate H-TLL-PE syringes were purchased from 
Innovative Labor Systeme (Stutzerbach, Germany). Microline ethyl vinyl acetate tube with 0.51 
mm inner and 1.52 mm outer diameters was bought from Fisher Scientific (Wohlen, Switzerland). 
Pluronic F-127 was purchased from Sigma-Aldrich (Buchs, Switzerland). M9 buffer was obtained 
by adding 3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 mL 1 M MgSO4, H2O to 1 litre and sterilization 
by autoclaving. Pluronic F127 solution was prepared by diluting 0.02% (weight/volume) Pluronic 
F127 in M9. 
 
C. elegans strains and culture  
C. elegans strains were cultured at 20°C on nematode growth media agar plates seeded with 
Escherichia coli strain OP50, unless stated otherwise. Strains used were wild-type Bristol N2, 
DA465 eat-2(ad465) II, MQ887 ips-1(qm150) XX, SJ4100 (zcIs13[hsp-6::GFP]), SJ4103 
(zcIs14[myo-3::GFP(mit)]), SJ4143 (zcIs17[ges-1::GFP(mit)]), TK22 mev-1(kn1). Strains were 
provided by the Caenorhabditis Genetics Center (University of Minnesota). The AG1073 (Prab-
3::cco-1HP;hsp-6::gfp) strain of worms was kindly provided by Andrew Dillin (UC Berkeley, CA, 
USA). Worms were suspended in M9 solution prior to each microfluidic experiment. Microfluidic 
worm synchronization procedures are detailed in Figure 2.  
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Fabrication of the microfluidic chips  
Microfluidic devices were prepared by soft lithography33 using 2-layer SU-8 molds. Briefly, 
conventional photolithography was used to pattern a 35 μm-thick layer of SU-8 photoresist on 4-
inch wafers. A 85 μm-thick layer of SU-8 was then patterned on top of the first one. The silicon 
mold was then diced in 15 mm × 18 mm microchips, which were inserted at the bottom of an 
aluminum/polymethylmetacrylate (PMMA) mold for PDMS casting. 1.5 mm diameter steel pins 
were used to define the lateral connections of the device for the external tubing insertion. A liquid 
PDMS mixture (10:1 base:cross-linker weight ratio) was degassed, injected into the mold and 
cured at 100 °C for 1 h. Upon extraction from the mold, each PDMS chip was bonded by plasma-
activation to a 150 μm-thick glass coverslip. The chip was then connected to external tubing and 
enclosed in a PMMA holder (Figure 1a), designed for the observation of the device through any 
upright or inverted microscope and with any kind of objective. 
 
System control and microfluidic device operation 
A live-cell microscopy environmental control system (Visitron, Puchheim, Germany) allowed 
controlling the chip temperature over the whole duration of each experiment. The microfluidic 
operations were controlled using Nemesys syringe pump control software (Cetoni, Korbussen, 
Germany). Experimentally, the microfluidic chip was first filled with Pluronic F127 solution, 
incubated for 30 min inside the device, to prevent E.coli sticking and accumulation inside the 
microchannels34. Few worms from a non-synchronized population were suspended in 10 μL of 
M9 buffer and sucked in a microfluidic tube, which was then connected to the device. From this 
point on, the system was completely controlled by software, through the automated sequential 
steps described in Figure 2.  
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Automated operation of the platform 
In each experiment, worms and embryos are manipulated via sequences of fully automated 
operations (Fig. 2). A worm suspension is first injected into the microfluidic device through the top 
port (In1 of Fig. 2a) and directed towards the “worm synchronization filter” by opening the valve 
at “Out1”. The geometry of the chip is optimized for retaining inside the worm culture chamber 
only adult worms by simply selecting the correct flow rate for the sample injection. In practice, at 
a flow rate of 500 nL/s, in a few tens of seconds, all the larvae present in the suspension are 
directly washed out of the chip, while adult worms are kept inside the chamber both due to their 
larger size and their better swimming abilities/resistance against the flow (zoom of Fig. 2a and 
Supplementary Video 2). The number of worms retained inside the chamber is controlled by the 
concentration of young adults in the worm suspension injected into the device (typically, 5 to 10 
young adults per 10 μL suspension).  Alternatively, a L1-L4 larvae suspension can be injected at 
a flow rate of 100 nL/s to retain just L4 larvae inside the chamber. When needed, the number of 
captured worms can be adapted by running an optional “washing step”, where M9 buffer is 
injected for a few seconds along the In1-Out1 direction at higher flow rates (1 to 5 µL/s) 
(Supplementary Video 3). Upon isolation of a defined worm population inside the chamber, worms 
are cultured and can be eventually treated on-chip with specific drugs or chemicals (Fig. 2b). For 
worm culture/treatment, an E. coli suspension is injected in the chamber at a desired rate, through 
the In2-Out2 direction, while drugs or chemicals can be introduced in the chip at controlled 
concentration and precise instants of the worms’ lifespan. A simple increase of the flow speed 
inside the chamber along the In3-Out2 direction is then used to transfer the eggs present in the 
chamber towards the embryo-incubator array. In practice, a 200 nL/s flow of M9 buffer allows 
recovering all the eggs present in the chamber and isolating each of them in a single micro-
incubator via passive hydrodynamic trapping up to complete array filling (Fig. 2c and 
Supplementary Video 4). Parallel time-lapse imaging is then started, either for the full array or by 
scanning each individual embryo at high resolution, at desired frame rate, magnification and light 
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wavelengths, depending on the analysis of interest (Fig. 2d). Alternatively, parallel time-lapse 
imaging could be started at the beginning of the embryo collection phase, in order to monitor each 
embryo from the first moment of its trapping on. Brightfield imaging of the 20 trapped embryos 
takes 20 seconds, and this procedure is repeated every minute. In the fluorescence experiments, 
combined brightfield and fluorescent imaging of the 20 trapped embryos is done in 180 seconds, 
and this procedure is repeated every 15 minutes, to avoid phototoxicity effects on the embryos. 
The synchronization point in the development for all embryos can be chosen by using either the 
appearance of the bean stage or hatching. During live imaging, we apply a slow flow (5-10 nL/s) 
of M9 buffer along the In3-Out2 direction to assure stable positioning of the embryos in the array. 
Because of the large section difference between chamber and incubators, the flow speed is 
slower inside the culture chamber and this very gentle flow is strong enough to keep captured 
eggs in position, but not fast enough to transfer new eggs from the chamber to the array. 
Optionally, for sequential studies on embryo populations produced by the same worms at different 
periods of their full adult lifespan, worm culture can be maintained in the chamber by the perfusion 
of E. coli from In2 inside the chip. Both the valves at Out1 and Out2 are left open in this case, and 
the different hydrodynamic resistances of the two orthogonal directions result in a partitioning of 
the flow between the two outlets, with most of the liquid flowing through Out1. This establishes a 
slow flow through the incubator array, ensuring stable positioning of the embryos over long 
periods, while still reducing E. coli accumulation in the array area, which could compromise the 
results of embryo fluorescent imaging, because of the autofluorescence of E. coli bacteria.    
 
Image acquisition and processing 
The microfluidic chip was integrated onto an inverted microscope (Axio Observer, Zeiss) equipped 
with two illumination systems: (i) a precisExcite High-Power LED Illumination system (Visitron, 
Puchheim, Germany) for brightfield imaging and (ii) a Lambda DG4 illumination system (Sutter 
instruments, Novato, CA, USA) for fluorescence imaging. The microscope had a motorized xy-
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stage, equipped with an ASI piezo controller for z-displacement (Visitron, Puchheim, Germany) 
and the automated imaging process was controlled using VisiView Premier Image acquisition 
software (Visitron, Puchheim, Germany).  
To start the automated imaging process, the position of the first egg in the array was set as initial 
point of the xy-stage scanning, while the locations of the other eggs were automatically 
determined by the interdistance between adjacent incubators (118 μm). A “wavelength program” 
was set on the software, to automatically switch between brightfield and fluorescent imaging 
modes, by controlling both the illumination systems. “Time-lapse” and “stage position” programs 
were set to automatically perform scanning and imaging over the full array at a desired rate, hence 
resulting in parallel time-lapse imaging of all the embryos. To avoid phototoxicity effects during 
these fluorescence imaging experiments, we minimized the exposure time of the embryo to the 
fluorescent excitation light (t < 100 ms) and pictures were recorded at a single focal plane of the 
microscope (i.e. at a single z value), despite the possibility of taking z-stacks with our setup. The 
movement of the embryo inside its eggshell during the twitching phase could sometimes introduce 
instantaneous modulations in the collected fluorescent intensity, because of the time-dependent 
positioning of the developing larva inside the focal volume of the microscope objective, but 
variations of the average fluorescent intensity of the embryo in a given xy-plane remained 
relatively small. The fluctuations in fluorescent intensity due to twitching of the embryo are smaller 
than the error bars in Figures 4 and 5. For each fluorescent picture, GFP intensity values were 
measured as average pixel intensity over the area occupied by the single embryo under 
observation. A background value was then measured for each picture as average pixel intensity 
over the microchannel area and this value was subtracted from the previously calculated one, to 
exclude the influence of any external autofluorescence sources from the measurement.  
Moreover, unspecific GFP expression is avoided by the use of tissue-specific promoters, e.g. the 
myo-3 promoter triggers GFP expression in the body wall muscles, while the ges-1 promoter in 
the intestinal cells only. 
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A simple Matlab script (MathWorks, Natick, MA, U.S.A) was written to reorder the large amount 
of data of each experiment according to the image xy-coordinates, time, light wavelength and 
exposure time. Image processing was performed with Fiji software (http://imagej.nih.gov/ij; 
version 1.47b).  
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Figure legends 
Figure 1 | Overview of the microfluidic device. (a) Picture of the microfluidic device, sizing 25 
mm x 75 mm (standard microscope slide size), including lateral microfluidic connections, which 
make the device compatible for imaging with every upright or inverted microscope. Scale bar = 
10 mm (bi) Schematic representation of the central part of the microfluidic chip, having as main 
constitutive parts: the worm culture chamber, the embryo-incubator array, four inlets (In1 to In4) 
and two outlets (Out1 and Out2). Scale bar = 2 mm (bii) Zoom on the worm culture chamber, 
including a drawing of young adult C.elegans for size comparison. The chamber is delimited by 
specific microfluidic channel arrangements, tailored for different functions: (top) worm injection, 
(bottom) worm synchronization, (left) E.coli / drug delivery and (right) egg transfer. Scale bar = 
500 μm (biii) Three-dimensional schematic zoom on a portion of the embryo incubator array. (c) 
Finite element method simulation (Comsol Multiphysics) of the fluid dynamics in the incubator 
array region, showing the principle of passive hydrodynamic arraying of single embryos. Fluidic 
velocity and streamlines are calculated for a flow rate of 100 nL/s at the inlet In3. Scale bar = 50 
μm (d) Micrograph of a single incubator on the SU-8/silicon master mold used for PDMS casting. 
(e) Micrograph of a section of the array with immobilized embryos. Scale bar = 100 μm (f) 
Illustration of the multi-dimensional imaging that is enabled on the array of embryos and spans 
six dimensions: the 3 spatial coordinates, time, exposure type and embryo number in the array. 
Figure 2 | Operation of the microfluidic device. (a) First a 10 L suspension of worms in M9 
buffer is injected into the microfluidic device along the In1-Out1 direction at a flow rate of 500 
nL/s. Symbols used for the in- and outlets: dot and arrow = syringe in use (e.g. In1); dot = syringe 
not in use (e.g. In2); circle = open valve (e.g. Out1); cross and circle = closed valve (e.g. Out2).  
The “worm synchronization filter” is tailored to retain inside the chamber only adult worms, as 
selected by their larger size and their better swimming abilities (see picture in zoom). (b) 
Subsequently worm culture is controlled by periodically injecting E.coli in M9 buffer along the In2-
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Out2 direction, typically at 50 nL/s flow rate. This ensures normal development of the worms in 
the liquid environment and continuous embryo production during their adult lifespan (see picture 
in zoom). Optionally, drugs or chemicals can be introduced at the In4 inlet for on-chip worm 
treatment. (c)  Injection of M9 buffer at 200 nL/s flow rate along the In3-Out2 direction triggers the 
transfer of all the eggs present in the chamber towards the incubator array, where they are 
captured by passive hydrodynamics, as shown by the superposition of 13 video frames in the 
zoom. (d) The perfusion of E.coli suspension towards both Out1 and Out2 simultaneously ensures 
proper worm feeding inside the culture chamber and stable embryo positioning inside the 
incubators, enabling parallel time-lapse imaging of the embryos at cellular resolution (see picture 
in zoom).  
Figure 3 | Study of C.elegans embryogenesis. (a) Time-lapse of the main embryonic stages of 
development with typical time indications for T= 25°C and wild-type worms. (b) Full embryonic 
development from egg capture in the incubator till hatching, as observed in a sequence of 
brightfield microscopy images (63× oil immersion objective, NA 1.4)  taken from a movie (1 frame 
per minute) at 45 min intervals for a N2 wild-type worm strain at 25°C; the hatching time defines 
t=0. Scale bars = 10 μm (c) Illustration of main embryonic development phases –1 cell to bean; 
bean to 1.5-fold; 1.5-fold to hatching– that are clearly morphologically distinguishable. (d) Duration 
of development phases, as observed for an array of 20 embryos for a N2 wild-type worm strain 
at 25°C; (di) variation of the time duration the embryo spends in an incubator, originating from 
differences in the exact moment of egg laying and trapping of the embryo; (dii) average duration 
of development phases, as obtained from the data in (di). (e) Duration of different development 
phases –bean to 1.5-fold; 1.5-fold to hatching– for the N2 wild-type strain of worms and a number 
of transgenic strains and mutants (Supplementary Note 6). Bar graphs are expressed as 
mean+SEM, *** p≤0.001.  (f) Pictures of a full array of 20 embryos taken 600 min after trapping 
in the incubators, illustrating the blocked development when the embryos are laid by N2 wild-type 
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worms that were exposed in the culture chamber to 2 mM of the anticancer drug 5-fluorouracil (5-
FU) in M9 buffer. Scale bars = 10 μm  
Figure 4 | Study of mitochondrial biogenesis. (a) Schematic representation of the 
mitochondrial unfolded protein response (UPRmt), as known for the larval and adult stages of the 
nematode C.elegans. (b-d) Merges of optical brightfield and fluorescent pictures of the Pmyo-
3::mito::gfp embryos and (e-g) the corresponding GFP quantification over the whole time-span 
from embryo capture to hatching (n=4). Pictures are grouped in blocks of same experimental 
observation and image representation conditions (exposure time and maximum displayed pixel 
intensity). (h-j) Merges of optical brightfield and fluorescent pictures of the Pges-1::mito::gfp 
embryos and (k-m) the corresponding GFP quantification over the whole time-span from embryo 
capture to hatching (n=14). Pictures are grouped in similar blocks as for the Pmyo-3::mito::gfp 
embryos. For (e-g) and (k-m), the curves correspond to the relative GFP induction compared to 
the initial time point in (e) and (k), respectively, of the experiments. Bar graphs are expressed as 
mean+SEM, * p≤0.05, points below a horizontal line are significantly different from the 
corresponding control.  Scale bars = 10 μm. 
Figure 5 | Study of mitochondrial unfolded protein response (UPRmt) during 
embryogenesis. (a-c) Representative optical brightfield and corresponding fluorescent pictures 
that show the hsp-6::gfp expression in (a) wild type, (b) isp-1(qm150), and (c) Prab-3::cco-1HP 
strains. (d-f) Quantification of the hsp-6::gfp induction in (d) wild type, (e) isp-1(qm150) and (f) 
Prab-3::cco-1HP strains over the whole time-span from embryo capture to hatching (n=17, 7, and 
21, respectively). The curves correspond to the relative GFP induction compared to the initial time 
point of each experiment. The blue area in each graph represents the base level 95% interval of 
confidence for each experiment. Bar graphs are expressed as mean+SEM, * p≤0.05, points below 
a horizontal line are significantly different from the corresponding control. (g-h) Comparison of the 
relative wild type hsp-6::gfp induction with the one of the (g) isp-1(qm150) and (h) Prab-3::cco-
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1HP strains. Bar graphs are expressed as mean+SEM, * p≤0.05, *** p≤0.001. (i-j) Localization of 
the hsp-6::gfp expression in the embryonic tissues, as observed in a period starting 60 min before 
hatching, for the (i) isp-1(qm150) and (j) Prab-3::cco-1HP strains. Scale bars = 10 μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
